Early-phase study results showed that treatment with a novel drug elicits promising outcomes in patients with advanced or metastatic triple-negative breast cancer.
Chris Ryan
Advertisement
Articles by Chris Ryan
Advertisement
Advertisement
Advertisement
Trending on CURE
1
Repeated Injections Double Progression-Free Survival in Glioblastoma
2
GLP-1s: Weight Loss and Survival in Breast Cancer Recovery
3
FDA Approves Sarclisa Escena as a New Under the Skin Treatment Option for Multiple Myeloma
4
Balance Exercise Package for Patients With Cancer: Improve Stability With Tandem Standing
5